Healthcare Triangle Launches AI Subsidiary QuantumNexis Through Strategic Acquisitions to Transform Healthcare Technology

Healthcare Triangle, Inc. (Nasdaq: HCTI) announced the launch of QuantumNexis, Inc., a new subsidiary focused on AI-powered SaaS solutions for the global healthcare market, executed through simultaneous acquisitions of Niyama Healthcare and Ezovion Solutions. This strategic expansion positions HCTI as a next-generation leader in generative AI-powered healthcare technology by integrating mental wellness and hospital intelligence platforms to address urgent global demands in clinical efficiency and healthcare accessibility.

The acquisition of Niyama Healthcare brings a fully digital, evidence-based mental wellness platform that integrates holistic medicine with a proprietary Generative AI engine personalizing treatment using comprehensive analytics across psychological, physical, and behavioral data. The platform, accessible via mobile or desktop at https://www.niyama.ai, supports psychiatry, clinical psychology, medical yoga, and nutrition, having piloted over 5000 clients and meeting rising demand for flexible, AI-assisted mental healthcare.

Ezovion Solutions contributes a modular, cloud-based AI-powered hospital information system that connects care workflows across diagnostics, medications, EHR, and revenue cycle management. Built on FHIR/HL7-compliant infrastructure and deployed in over 325 hospitals across Asia and MEA, the platform available at https://www.ezovion.com empowers hospitals to deliver smarter, real-time care through advanced analytics and AI-driven decision support with enhanced operational visibility across clinical and administrative functions.

Sujatha Ramesh, Chief Operating Officer of HCTI, stated that QuantumNexis marks a pivotal step in their growth strategy by separating Gen AI SaaS innovation from traditional services, launching an intelligent global healthcare platform that delivers measurable impact at scale. David Ayanoglou, Chief Financial Officer, added that this structure unlocks significant valuation upside by isolating their fastest-growing business, improving transparency, enhancing capital strategy, and positioning HCTI for long-term shareholder value creation.

The launch establishes HCTI as a focused player in Gen AI healthcare SaaS, delivering powerful solutions to underserved markets while enabling margin expansion through automation and product-led growth. This move reaffirms the company's commitment to innovation, financial discipline, and sustainable market leadership in addressing critical healthcare challenges through advanced technology integration.